期刊文献+

JAK2V617F及MPLW515L/K在骨髓增殖性肿瘤中的表达和意义 被引量:1

原文传递
导出
摘要 骨髓增殖性肿瘤(MPNs)是一类起源于多能造魄干细胞的疾病。近年来,JAK2V617F等突变基因的发现使得人们对MPNs发病机制的研究取得了长足的进步,认识到JAK2V617F可引起蛋白酪氨酸激酶信号途径(JAK-STAT)过度活化,进而导致疾病发生。此外,MPLW515L/K等其他一系列新发现的异常基因更进一步阐明了JAK2-MPNs的发病机制。本文就BCR/ABL-MPNs中的特征性突变基因的结构功能、在MPNs发病中所起的作用、对于疾病诊断的意义以及应用JAK2抑制剂靶向治疗MPNs的前景作一综述。
出处 《国际输血及血液学杂志》 CAS 2009年第1期63-66,共4页 International Journal of Blood Transfusion and Hematology
  • 相关文献

参考文献24

  • 1Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002, 100(7) :2292-2302.
  • 2Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point of-care diagnostic algorithms. Leukemia, 2008,22 ( 1 ) : 14-22.
  • 3Rawlings JS, Rosier KM, Harrison DA. The JAK/STAT signa ling Pathway. J Cell Sci, 2004, 117 (Pt 8):1281-1283.
  • 4Saharinen P, Takaluoma K, Silvennoinen O. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol Cell Biol, 2000, 20(10):3387-3395.
  • 5Levine RI., Loriaux M, Huntly BJ, et al. The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood,2005, 106(10) :3377-3379.
  • 6Fialkow JP, Faguet GB, Jacobson RJ, et al. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood, 1981, 58(5):916-919.
  • 7Kaushansky K. On the molecular origins of the chronic myeloproliferative disorders: it all make sense. Blood, 2005, 105 (11) : 4187-4190.
  • 8Jamieson CH, Gotlib J, Durocher JA, et al. The JAK2V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A, 2006, 103(16):6224-6229.
  • 9Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 2005, 7(4):387-397.
  • 10Ugo V, Marzac C, Teyssandier I,et al. Multiple signaling pathways are are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera. Exp Hematol, 2004, 32(2) :179-187.

二级参考文献35

共引文献29

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部